The Food and Drug Administration today adjusted its import screening to expedite personal protective equipment and clarified types of PPE that can be imported without engaging with FDA. To provide flexibility, FDA will facilitate access to critical legitimate PPE and devices and monitor the import systems to prevent and mitigate potential issues.

FDA established an email, COVID19FDAIMPORTINQUIRIES@fda.hhs.gov, for industry representatives to address questions or concerns. FDA also updated its FAQ on diagnostic testing for SARS-CoV-2 to answer additional questions

Related News Articles

Headline
The National Institutes of Health has halted a clinical trial evaluating the effectiveness of COVID-19 convalescent plasma in emergency department patients…
Headline
President Biden today announced a major partnership between Johnson & Johnson and Merck to manufacture the latest COVID-19 vaccine to be authorized for…
Headline
The AHA, American Medical Association, American Health Care Association, National Association for Home Care & Hospice, National Hospice and Palliative Care…
Headline
The federal government has agreed to purchase at least 100,000 doses of the combination monoclonal antibody therapy bamlanivimab and etesevimab, Eli Lilly…
Headline
The Food and Drug Administration Friday granted an emergency use authorization for Johnson & Johnson’s single-dose COVID-19 vaccine. Following the EUA’s…
Headline
The House of Representatives Saturday voted 219-212 to approve a modified version of the American Rescue Plan Act of 2021, legislation to provide…